[{"Assets_0_Q2_USD":384768000.0,"CommonStockSharesOutstanding_0_Q2_shares":76540055.0,"EarningsPerShareBasic_1_Q2_USD":-0.2,"EarningsPerShareBasic_2_Q2_USD":-0.61,"EarningsPerShareDiluted_1_Q2_USD":-0.2,"EarningsPerShareDiluted_2_Q2_USD":-0.61,"NetIncomeLoss_1_Q2_USD":-14187000.0,"NetIncomeLoss_2_Q2_USD":-37251000.0,"StockholdersEquity_0_Q2_USD":92422000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":70302.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":60650.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":70302.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":60650.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]